BioSpace News Archive

Business

iSpecimen Expands Proprietary Provider Network to Help Advance Infectious Disease Research

iSpecimen Inc. announced today that the Company has added several new infectious disease specimen providers to its global supply network.

October 26, 2023
·
3 min read
Biotech Bay

Better Therapeutics to Participate in the American College of Lifestyle Medicine’s 2023 Annual Conference

Better Therapeutics, Inc. today announced its participation in the American College of Lifestyle Medicine’s (ACLM) 2023 Lifestyle Medicine Annual Conference (LM2023), to be held October 29 to November 1, 2023, in Denver, Colorado.

October 26, 2023
·
6 min read
Business

Mainz Biomed Appoints Tarrin Khairi-Taraki as VP of Commercial Operations

Mainz Biomed N.V. is proud to announce the appointment of Tarrin Khairi-Taraki as Vice President of Commercial Operations, EMEA.

October 26, 2023
·
6 min read
Business

Pacira to Report Third Quarter 2023 Financial Results on Thursday November 2, 2023

Pacira BioSciences, Inc. announced that it will report its third quarter financial results before the open of the U.S. markets on Thursday November 2, 2023.

October 26, 2023
·
1 min read
Genetown

TransCode Therapeutics Announces Prolonged Survival in Murine Models with Glioblastoma Treated with Its Lead Candidate, TTX-MC138

TransCode Therapeutics, Inc., the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, announced significantly improved survival in murine models bearing human glioblastoma multiforme tumors treated with its lead therapeutic candidate, TTX-MC138.

October 26, 2023
·
7 min read
BioMidwest

Ocuphire Pharma to Present at AAO 2023 and Eyecelerator Retina Showcase

Ocuphire Pharma, Inc. today announced presentations featuring APX3330 and phentolamine ophthalmic solution at the American Academy of Ophthalmology Annual Meeting (AAO 2023) to take place in San Francisco, California on November 3-6, 2023.

October 26, 2023
·
6 min read
Pharm Country

Promontory Therapeutics to Present Data on PT-112 Mechanism of Action at the Society for Immunotherapy of Cancer’s 38th Annual Meeting

Promontory Therapeutics Inc. will present a poster demonstrating the molecular mechanism of its lead therapeutic candidate, PT-112, at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting. SITC is taking place November 1-5, 2023 in San Diego.

October 26, 2023
·
2 min read
Pixium Vision announces its financial results for H1 2023 and provides update

Pixium Vision SA, a bioelectronics company developing innovative vision systems to enable patients who have lost their sight to live more independent lives, announces its financial results for the first half of 2023.

October 26, 2023
·
8 min read
Drug Development

MaaT Pharma Announces Positive Outcome Following DSMB Review Reinforcing Confidence in Phase 3 On-Going Trial in Acute Graft-versus-Host Disease with MaaT013

MaaT Pharma announced that the DSMB unanimously recommended that the open-label, single arm pivotal Phase 3 clinical trial evaluating MaaT013 in acute Graft-versus-Host Disease, named ARES, continues without modification.

October 26, 2023
·
5 min read
Business

Qkine Appoints Thomas Scientific as New US Distribution Partner for Its Innovative Growth Factor and Cytokine Portfolio

Qkine, an industry-leading manufacturer of animal-free, highly pure recombinant proteins, is delighted to announce a sales distribution agreement with Thomas Scientific to enable fast and easy purchasing of Qkine growth factors and cytokines for stem cell scientists based in the United States.

October 26, 2023
·
2 min read